1. Home
  2. KNTK vs RYTM Comparison

KNTK vs RYTM Comparison

Compare KNTK & RYTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KNTK
  • RYTM
  • Stock Information
  • Founded
  • KNTK 2017
  • RYTM 2008
  • Country
  • KNTK United States
  • RYTM United States
  • Employees
  • KNTK N/A
  • RYTM N/A
  • Industry
  • KNTK Natural Gas Distribution
  • RYTM Biotechnology: Pharmaceutical Preparations
  • Sector
  • KNTK Utilities
  • RYTM Health Care
  • Exchange
  • KNTK Nasdaq
  • RYTM Nasdaq
  • Market Cap
  • KNTK 3.8B
  • RYTM 3.1B
  • IPO Year
  • KNTK N/A
  • RYTM 2017
  • Fundamental
  • Price
  • KNTK $65.12
  • RYTM $54.54
  • Analyst Decision
  • KNTK Buy
  • RYTM Strong Buy
  • Analyst Count
  • KNTK 9
  • RYTM 10
  • Target Price
  • KNTK $75.33
  • RYTM $66.90
  • AVG Volume (30 Days)
  • KNTK 575.6K
  • RYTM 580.8K
  • Earning Date
  • KNTK 02-26-2025
  • RYTM 02-20-2025
  • Dividend Yield
  • KNTK 4.79%
  • RYTM N/A
  • EPS Growth
  • KNTK 221.62
  • RYTM N/A
  • EPS
  • KNTK 2.62
  • RYTM N/A
  • Revenue
  • KNTK $1,446,081,000.00
  • RYTM $112,530,000.00
  • Revenue This Year
  • KNTK $6.41
  • RYTM $63.77
  • Revenue Next Year
  • KNTK $35.15
  • RYTM $44.91
  • P/E Ratio
  • KNTK $24.86
  • RYTM N/A
  • Revenue Growth
  • KNTK 20.20
  • RYTM 81.55
  • 52 Week Low
  • KNTK $31.73
  • RYTM $35.17
  • 52 Week High
  • KNTK $65.38
  • RYTM $68.58
  • Technical
  • Relative Strength Index (RSI)
  • KNTK 74.96
  • RYTM 43.02
  • Support Level
  • KNTK $62.01
  • RYTM $52.71
  • Resistance Level
  • KNTK $60.41
  • RYTM $60.12
  • Average True Range (ATR)
  • KNTK 1.51
  • RYTM 2.13
  • MACD
  • KNTK 0.67
  • RYTM -0.36
  • Stochastic Oscillator
  • KNTK 97.34
  • RYTM 23.48

About KNTK Kinetik Holdings Inc.

Kinetik is a midstream operator that provides gathering and processing services to gas and oil producers as well as pipeline transportation. It operates exclusively in Texas, serving the Permian Basin and connecting fields with market hubs and other large pipelines. In addition to directly operating pipelines, Kinetik also holds ownership stakes in several pipelines that transport molecules to the Gulf Coast enabling it to obtain exposure to export markets and international demand.

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in development and commercialization of therapies for patients with rare diseases. It is focused on the development and commercialization of peptide therapeutics for the treatment of gastrointestinal, or GI, diseases, and genetic deficiencies that result in metabolic disorders. The company's product candidate is setmelanotide (RM 493), which is a potent, melanocortin 4, or MC4, receptor agonist for the treatment of rare genetic disorders of obesity caused by MC4 pathway deficiencies. Geographically the company generates its revenue from the United states, Germany, and other with the majority being generated from the United states.

Share on Social Networks: